MicroRNA-802 suppresses breast cancer proliferation through downregulation of FoxM1

Yuan,Feng; Wang,Wei

doi:10.3892/mmr.2015.3921

MicroRNA-802 suppresses breast cancer proliferation through downregulation of FoxM1

Authors:
- Feng Yuan
- Wei Wang
View Affiliations

Affiliations: Department of Breast Cancer, Hubei Cancer Hospital, Wuhan, Hubei 430079, P.R. China
Published online on: June 12, 2015 https://doi.org/10.3892/mmr.2015.3921
Pages: 4647-4651

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

An increasing number of studies have shown that microRNAs (miRNAs) are critical in tumor cell proliferation, as they modulate key gene transcripts. In the present study, the expression and roles of miRNA (miR)‑802 were analyzed by quantitative polymerase chain reaction in breast cancer cells. The results showed that expression levels of miR‑802 were significantly reduced in breast cancer tissues and cells compared with those of normal tissue and normal breast epithelial cells. In vitro and in vivo experiments demonstrated that miR‑802 overexpression inhibited cell proliferation in MCF‑7 breast cancer cells and tumor growth in nude mice, respectively. Furthermore, mechanistic investigation with western blotting and luciferase reporter assays revealed that miR‑802 overexpression downregulated protein expression levels of Forkhead box protein M1 (FoxM1). Therefore, the results of the present study provided evidence for a previously undetermined miR‑802/FoxM1 molecular network, which was involved in the regulation of breast cancer cell proliferation.

View Figures

View References

1	Cao W, Wang X and Li JC: Hereditary breast cancer in the Han Chinese population. J Epidemiol. 23:75–84. 2013. View Article : Google Scholar : PubMed/NCBI
2	Assadi M, Lamerz J, Jarutat T, et al: Multiple protein analysis of formalin-fixed and paraffin-embedded tissue samples with reverse phase protein arrays. Mol Cell Proteomics. 12:2615–2622. 2013. View Article : Google Scholar : PubMed/NCBI
3	Asghar U, Witkiewicz AK, Turner NC and Knudsen ES: The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat Rev Drug Discov. 14:130–146. 2015. View Article : Google Scholar : PubMed/NCBI
4	Atalay C: New concepts in axillary management of breast cancer. World J Clin Oncol. 5:895–900. 2014. View Article : Google Scholar : PubMed/NCBI
5	Van Kouwenhove M, Kedde M and Agami R: MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer. 11:644–656. 2011. View Article : Google Scholar : PubMed/NCBI
6	Ameres SL and Zamore PD: Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol. 14:475–488. 2013. View Article : Google Scholar : PubMed/NCBI
7	Singh R and Mo YY: Role of microRNAs in breast cancer. Cancer Biol Ther. 14:201–212. 2013. View Article : Google Scholar : PubMed/NCBI
8	Redova M, Sana J and Slaby O: Circulating miRNAs as new blood-based biomarkers for solid cancers. Future Oncol. 9:387–402. 2013. View Article : Google Scholar : PubMed/NCBI
9	Pinho FG, Frampton AE, Nunes J, et al: Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferation. Cancer Res. 73:5936–5948. 2013. View Article : Google Scholar : PubMed/NCBI
10	Hwang MS, Yu N, Stinson SY, et al: miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer. PloS One. 8:e665022013. View Article : Google Scholar : PubMed/NCBI
11	Wang IC, Chen YJ, Hughes D, et al: Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol. 25:10875–10894. 2005. View Article : Google Scholar : PubMed/NCBI
12	Sansom SE, Nuovo GJ, Martin MM, Kotha SR, Parinandi NL and Elton TS: miR-802 regulates human angiotensin II type 1 receptor expression in intestinal epithelial C2BBe1 cells. Am J Physiol Gastrointest Liver Physiol. 299:G632–G642. 2010. View Article : Google Scholar : PubMed/NCBI
13	Kornfeld JW, Baitzel C, Konner AC, et al: Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature. 494:111–115. 2013. View Article : Google Scholar : PubMed/NCBI
14	Sengupta A, Kalinichenko VV and Yutzey KE: FoxO1 and FoxM1 transcription factors have antagonistic functions in neonatal cardiomyocyte cell-cycle withdrawal and IGF1 gene regulation. Circ Res. 112:267–277. 2013. View Article : Google Scholar :
15	Qu K, Xu X, Liu C, et al: Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma. Cancer Lett. 331:105–114. 2013. View Article : Google Scholar
16	Sanders DA, Ross-Innes CS, Beraldi D, Carroll JS and Balasubramanian S: Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells. Genome Biol. 14:R62013. View Article : Google Scholar : PubMed/NCBI
17	Yang C, Chen H, Tan G, et al: FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer. Cancer Lett. 340:104–112. 2013. View Article : Google Scholar : PubMed/NCBI
18	Halasi M, Pandit B, Wang M, Nogueira V, Hay N and Gartel AL: Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth. Am J Pathol. 183:257–265. 2013. View Article : Google Scholar : PubMed/NCBI
19	Li J, Wang Y, Luo J, et al: miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells. FEBS Lett. 586:3761–3765. 2012. View Article : Google Scholar : PubMed/NCBI
20	Ke Y, Zhao W, Xiong J and Cao R: miR-149 Inhibits non-small-cell lung cancer cells EMT by targeting FOXM1. Biochem Res Int. 2013:5067312013. View Article : Google Scholar : PubMed/NCBI
21	Feng Y, Wang L, Zeng J, et al: FoxM1 is overexpressed in Helicobacter pylori-induced gastric carcinogenesis and is negatively regulated by miR-370. Mol Cancer Res. 11:834–844. 2013. View Article : Google Scholar : PubMed/NCBI